Yohei Doi

InstitutionUniversity of Pittsburgh School of Medicine
AddressPittsburgh
Pennsylvania
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in May 2021
    All Publications
    Bar chart showing 222 publications over 20 distinct years, with a maximum of 28 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shindo Y, Kondoh Y, Kada A, Doi Y, Tomii K, Mukae H, Murata N, Imai R, Okamoto M, Yamano Y, Miyazaki Y, Shinoda M, Aso H, Izumi S, Ishii H, Ito R, Saito AM, Saito TI, Hasegawa Y. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure. Infect Dis Ther. 2021 Dec; 10(4):2353-2369. PMID: 34368914.
      Citations:    
    2. Suzuki M, Imai T, Sakurai A, Komoto S, Ide T, Lim CK, Shintani A, Doi Y, Murata T. Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort. J Infect Chemother. 2021 Sep; 27(9):1350-1356. PMID: 34176716.
      Citations:    Fields:    Translation:Humans
    3. Murata T, Sakurai A, Suzuki M, Komoto S, Ide T, Ishihara T, Doi Y. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers. mSphere. 2021 05 19; 6(3). PMID: 34011679.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    4. Yamagishi T, Doi Y. Insights on Coronavirus Disease 2019 Epidemiology From a Historic Cruise Ship Quarantine. Clin Infect Dis. 2021 05 18; 72(10):e458-e459. PMID: 32798226.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Fujigaki H, Inaba M, Osawa M, Moriyama S, Takahashi Y, Suzuki T, Yamase K, Yoshida Y, Yagura Y, Oyamada T, Takemura M, Doi Y, Saito K. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients. J Immunol. 2021 05 15; 206(10):2393-2401. PMID: 33941657.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    6. Inaba M, Higashimoto Y, Toyama Y, Horiguchi T, Hibino M, Iwata M, Imaizumi K, Doi Y. Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection. Int J Infect Dis. 2021 Jun; 107:195-200. PMID: 33862213.
      Citations: 7     Fields:    Translation:Humans
    7. Tsukamoto T, Nakajima N, Sakurai A, Nakajima M, Sakurai E, Sato Y, Takahashi K, Kanno T, Kataoka M, Katano H, Iwata M, Doi Y, Suzuki T. Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and Streptococcus pneumoniae. Emerg Infect Dis. 2021 03; 27(3):919-923. PMID: 33443011.
      Citations: 1     Fields:    Translation:HumansCells
    8. Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M. A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19. Antimicrob Agents Chemother. 2020 11 17; 64(12). PMID: 32958718.
      Citations: 41     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    9. Fujigaki H, Takemura M, Osawa M, Sakurai A, Nakamoto K, Seto K, Fujita T, Hata T, Akiyama H, Doi Y, Saito K. Reliability of serological tests for COVID-19: comparison of three immunochromatography test kits for SARS-CoV-2 antibodies. Heliyon. 2020 Sep; 6(9):e04929. PMID: 32984615.
      Citations: 2     
    10. Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, Iwata M, Morise Z, Doi Y. Natural History of Asymptomatic SARS-CoV-2 Infection. N Engl J Med. 2020 08 27; 383(9):885-886. PMID: 32530584.
      Citations: 93     Fields:    Translation:HumansCellsPHPublic Health